Zentalis Pharmaceuticals Inc (ZNTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 0 | 0 | 0 | 0 | 26,865 |
| Gross Profit | N/A | N/A | N/A | N/A | 26,865 |
| Operating Expenses | 37,393 | 33,734 | 36,058 | 45,623 | 76,714 |
| Operating Income | -37,393 | -33,734 | -36,058 | -45,623 | -49,849 |
| Other Income | 2,619 | 7,043 | 9,184 | -2,656 | 2,172 |
| Pre-tax Income | -34,774 | -26,691 | -26,874 | -48,279 | -47,677 |
| Income Tax | N/A | N/A | 0 | N/A | -205 |
| Net Income Continuous | -35,216 | -26,691 | -26,874 | -48,279 | -47,472 |
| Net Income | $-35,216 | $-26,691 | $-26,874 | $-48,279 | $-47,472 |
| EPS Basic Total Ops | -0.50 | -0.37 | -0.37 | -0.67 | -0.67 |
| EPS Basic Continuous Ops | -0.49 | -0.37 | -0.37 | -0.67 | -0.67 |
| EPS Diluted Total Ops | -0.50 | -0.37 | -0.37 | -0.67 | -0.67 |
| EPS Diluted Continuous Ops | -0.49 | -0.37 | -0.37 | -0.67 | -0.67 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.37 | -0.37 | -0.67 | -0.66 |
| EBITDA(a) | $-37,667 | $-34,091 | $-36,679 | $-46,395 | $-47,193 |